课题基金 / 基金详情

Clinical Center for The Parkinson Disease Neuroprotection Clinical Trial

Clinical Center for The Parkinson Disease Neuroprotection Clinical Trial
帕金森病神经保护临床试验临床中心
批准号:
8460258
负责人:
Ramon L. Rodriguez
金额:
$9.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-17 至 2015-11-30

项目摘要

项目成果

Ramon L. Rodriguez的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该提案的目标是作为临床站点参与早期帕金森氏病(PD)患者的神经保护剂的探索性试验。帕金森病是一种进展缓慢的神经系统疾病,会导致严重的残疾。目前的治疗方法并不能改变疾病的进程。然而,已经确定了一些新的化合物,它们有可能减缓甚至阻止帕金森病的进展。如果这些化合物中的任何一种能够真正保护存活的神经元免受退化,它们将延缓甚至防止数百万帕金森病患者的严重残疾。我们这个项目的主要目标将是保留目前在神经保护领域的研究对象。 试点研究LS-1,以及继续参与随后的第三阶段试验,解决帕金森病的疾病修改治疗。佛罗里达大学将作为一个网站,在两个UF附属的运动障碍临床试验中心-盖恩斯维尔的斯汉兹和杰克逊维尔的斯汉兹-两个分支机构。这两个网站都将作为佛罗里达大学旗下的财团网站,仿照目前在Net-PD试验中成功招募的一些财团中心的模式。由于两个高质量的运动障碍中心位于种族多元化的大都市地区,为佛罗里达州中北部和东北部的几乎所有退伍军人和非退伍军人提供服务,我们预计很容易保留目前登记的受试者,以及在未来的研究中招募。每个中心及其研究人员都有成功参与、登记和合作PD多中心试验的令人印象深刻的历史。UF中心的招募和招募调查员是接受过运动障碍方面的奖学金培训的。此外,我们致力于保护所有人体试验受试者,并将积极努力保留目前登记的受试者。这些都是我们的首要任务。在每所院校,我们将尽一切可能确保保留目前注册的科目,这是我们非常致力于的。
英文摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to participate as a clinical site in exploratory trials of neuroprotective agents for patients with early Parkinson's Disease (PD). PD is a slowly progressive neurological disorder which results in severe disability. Current therapies do not alter the course of the disease. However, a number of new compounds have been identified that have the potential to slow down or even halt the progression of PD. If any of these compounds can truly protect viable neurons from degenerating, they would delay or even prevent significant disability in the millions of patients who suffer from PD. Our primary objectiv with this project will be to retain the currently enrolled research subjects in the neuroprotection pilot study LS-1, as well as continue participation in subsequent phase III trials addressing disease modifying therapy in PD. The University of Florida will act as one site with two branches at two UF-affiliated Movement Disorder Clinical Trial Centers: Shands at Gainesville and Shands at Jacksonville. Both sites will be acting as consortia sites under the tianner of the University of Florida, modeled after some of the current consortia Centers that successfully recruited as a group in the previous NET-PD trials. With two high-quality Movement Disorders Centers located in ethnically-diverse metropolitan areas serving almost the entire veteran and non-veteran population of North-Central and North-Eastern Florida, we anticipate easy retention of the currently enrolled subjects as well as recruitment in future studies. Each Center and its investigators carry an impressive history of successful participation, enrollment and collaboration in PD multi-center trials. The recruiting and enrolling investigators at the UF Centers are fellowship-trained in Movement Disorders. Furthermore, we are committed to the protection of all human trials subjects and will actively work to retain currently enrolled subject. These are our highest priorities. At each institution, every possible effort will be performed to ensure retention of the currently enrolled subjects, which we are extremely commited to.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Center for the Parkinson Disease Neuroprotection Clinical Trial
  • 批准号:
    8242192
  • 项目类别:
  • 资助金额:
    $26.93万
  • 财政年份:
    2006
  • 负责人:
    Ramon L. Rodriguez
  • 依托单位:
Clinical Center for The Parkinson Disease Neuroprotection Clinical Trial
  • 批准号:
    8601340
  • 项目类别:
  • 资助金额:
    $2.3万
  • 财政年份:
    2006
  • 负责人:
    Ramon L. Rodriguez
  • 依托单位:
Clinical Center for the Parkinson Disease Neuroprotection Clinical Trial
  • 批准号:
    7779494
  • 项目类别:
  • 资助金额:
    $23.46万
  • 财政年份:
    2006
  • 负责人:
    Ramon L. Rodriguez
  • 依托单位:
海外基金